GILD
GILEAD SCIENCES, INC.
NASDAQ · Healthcare · Drug Manufacturers - General · US
$172.31
+2.89%Forward multiples
Based on analyst estimates
- P/E forward
- 19.90x
- P/E 2026E
- —
- P/E 2027E
- 16.87x
- P/E 2028E
- 15.76x
- P/S forward
- 6.57x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 16.39x
- Price / sales
- 6.90x
- Price / cash flow
- 14.76x
Enterprise value
- Enterprise value
- $233.4B
- EV / sales
- 7.53x
- EV / EBITDA
- 283.64x
- EV / EBIT
- -171.89x
- Market cap
- $213.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026